Moderna lost a fifth of its market value as the mRNA vaccine maker after forecasting revenue well below market expectations. Intra-Cellular Therapies stock however soared on a [$15 billion deal to be ...

The company said Monday that it will provide a $119.5 million investment in Truveta's Series C financing round and help launch the company's Truveta Genome Project, which will extend Regeneron's ...

Abercrombie & Fitch raised its sales outlook after posting better-than-expected results in the holiday period, citing a positive consumer response to the company's product selection and its marketing ...

Bausch + Lomb moved to bolster the eye-care company's pipeline of clinical-stage offerings with the acquisition of Whitecap Biosciences, a firm developing two therapies for potential use in glaucoma ...

Cineplex said the momentum that began in November thanks to a slate of blockbuster films including "Moana 2" and "Wicked" continued to bring customers to the screens. Wicked is the highest-grossing ...

Shares of Arcutis Biotherapeutics jumped after the company offered fourth-quarter preliminary product revenue results that topped analyst expectations. The stock was up 8% at $14.92 in premarket ...

Oil futures were up strongly Monday, with Brent crude on track for its first finish above $80 a barrel since August, as ...

Galliford Try Holdings said it has been awarded a five-year contract with Yorkshire Water worth about 100 million pounds ($122.1 million). The British construction group said Monday that the contract ...

Clearwater Analytics struck a deal to buy software company Enfusion in a deal worth $1.5 billion, bolstering its efforts to build a cloud platform for the investment-management industry.

The White House on Monday announced new restrictions on artificial intelligence exports that will impact companies including ...

Johnson & Johnson agreed to acquire Intra-Cellular Therapies for $132 a share in cash for a total equity value of about $14.6 billion. The health-care company Monday said the deal adds to its ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...